Angiosarcoma

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Agnostic Therapy in Rare Solid Tumors

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

Propranolol in Angiosarcoma

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma